These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3875605)

  • 21. Antibacterial activity of an oral penem, Sch 29482.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():49-57. PubMed ID: 6977533
    [No Abstract]   [Full Text] [Related]  

  • 22. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Aug; 6(4):460-6. PubMed ID: 3117535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria.
    Pechère JC; Letarte R; Guay R; Asselin C; Morin C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():123-32. PubMed ID: 6977528
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
    Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
    Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro antibacterial activity of AMA-1080.
    Matsuda K; Hamana Y; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1985 Nov; 16(5):539-47. PubMed ID: 3878360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in-vitro activity of Sch 34343, a new penem antibiotic.
    Reeves DS; Holt HA; Bywater MJ
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():57-66. PubMed ID: 3849538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics.
    Cherian PT; Deshpande A; Cheramie MN; Bruhn DF; Hurdle JG; Lee RE
    J Antibiot (Tokyo); 2017 Jan; 70(1):65-72. PubMed ID: 27189120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sch 29482--a novel penem antibiotic: an in-vitro comparison of its activity with other beta-lactams.
    Brown RM; Wise R; Andrews JM
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():17-23. PubMed ID: 6977530
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-lactamases as the main resistance factor to penicillin-related antibiotics.
    Frère JM; Joris B
    Ann Biol Clin (Paris); 1988; 46(2):151-6. PubMed ID: 3260085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of BRL 42715, a beta-lactamase-inhibiting penem.
    Qadri SM; Ueno Y; Burdette M; Kroschinsky R; Almodovar E
    Chemotherapy; 1991; 37(6):398-404. PubMed ID: 1760938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition.
    Barry AL; Jones RN; Wilson HW; Badal RE; Thornsberry C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():97-112. PubMed ID: 6977536
    [No Abstract]   [Full Text] [Related]  

  • 40. In-vitro antimicrobial activity of Sch 29842, a new beta-lactam antibiotic.
    Mitsuhashi S; Inoue M; Saino Y; Ogashiwa M
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():91-5. PubMed ID: 6977535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.